Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

CompletedOBSERVATIONAL

Enrollment

1,031

Participants

Timeline

Start Date

September 19, 1996

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions

MelanomaOvarian CancerProstate CancerBreast CancerLymphoma

Trial Locations (1)

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00001503 - Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease | Biotech Hunter | Biotech Hunter